Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Apply
Pidnarulex & Trastuzumab Deruxtecan
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step